{"id":1613,"date":"2020-02-25T23:23:20","date_gmt":"2020-02-25T23:23:20","guid":{"rendered":"http:\/\/www.trendsandtargets.com\/?p=1613"},"modified":"2020-02-26T08:24:52","modified_gmt":"2020-02-26T08:24:52","slug":"moderna-cocrystal-pharma-26-02-2020","status":"publish","type":"post","link":"http:\/\/www.trendsandtargets.com\/index.php\/2020\/02\/25\/moderna-cocrystal-pharma-26-02-2020\/","title":{"rendered":"Moderna & Cocrystal Pharma 26\/02\/2020"},"content":{"rendered":"\n

#Nasdaq #SP500<\/strong> With a few UK stocks going ballistic due to China Virus activity, a glance at the US highlights a couple of shares enjoying time in the medical spotlight. #Moderna & #Cocrystal both deserve some examination, along with a reminder prices which go up fast can equally reverse with greater brutality.<\/p>\n\n\n\n

In plain English, we’re focused on the numbers but remember checking out some fundamentals makes a lot of sense.<\/p>\n\n\n\n

Moderna, at time of writing 24.5, has \nbeen quite encouraging, the share price needing trading beyond 26.6 dollars to \nenter a near term cycle to 29.29 dollars. If bettered, secondary calculates at \n31.03 dollars though, to be fair, any enthusiastic publicity feels capable of \ndriving the price to 36 dollars. We cannot calculate higher.<\/p>\n\n\n\n

Visually, the proximity of our \ninitial two target levels tends suggest the possibility of some hesitation \naround the 30 dollar mark. Any reversal needs break RED (currently 18) on the \nchart to justify hysterics, along with the risk of reversal to 9.95 and \nhopefully a rebound.<\/p>\n\n\n\n

\"Hey,<\/figure>\n\n\n\n

Cocrystal Pharma, presently 2.15, \nlooks very capable of some excitement with trades now above 2.5 dollars as \ngrowth to an initial 3.69 appears possible. In the event this level is exceeded, \nour secondary calculates at an amazing (and therefore questionable) 5.46. Our \nin-house cautious nature makes us hesitant, when describing a scenario allowing \na price to more than double but such is the nature of the current panic, it’d be \nchurlish not to admit this possibility.<\/p>\n\n\n\n

The price would require to slip below \nBlue, presently 1.45, to suggest an alternative investment in running shoes!<\/p>\n\n\n\n

\"Hey,<\/figure>\n\n\n\n<\/p>\n\n\n
\n\t

Time Issued<\/font><\/td>

\n\t

Market<\/font><\/td>

\n\t

Price At Issue<\/font><\/td>

\n\t

Short Entry<\/font><\/td>

\n\t

Fast Exit<\/font><\/td>

\n\t

Slow Exit<\/font><\/td>

\n\t

Stop<\/font><\/td>

\n\t

Long Entry<\/font><\/td>

\n\t

Fast Exit<\/font><\/td>

\n\t

Slow Exit<\/font><\/td>

\n\t

Stop<\/font><\/td>

\n\t

Prior<\/font><\/td> <\/TR>\nFUTURES<\/font><\/a>

\n\t

9:33:22PM<\/font><\/td>

\n\t

BRENT<\/font><\/td>

\n\t

54.28<\/font><\/td>

\n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t

‘cess<\/font><\/td> <\/TR>\n

\n\t

9:35:59PM<\/font><\/td>

\n\t

GOLD<\/font><\/td>

\n\t

1635.07<\/font><\/td>

\n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t

Success<\/font><\/td> <\/TR>\n

\n\t

9:41:41PM<\/font><\/td>

\n\t

FTSE<\/font><\/td>

\n\t

6951.4<\/font><\/td>

\n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t

Success<\/font><\/td> <\/TR>\n

\n\t

9:50:11PM<\/font><\/td>

\n\t

FRANCE<\/font><\/td>

\n\t

5603.7<\/font><\/td>

\n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t

Shambles<\/font><\/td> <\/TR>\n

\n\t

10:29:52PM<\/font><\/td>

\n\t

GERMANY<\/font><\/td>

\n\t

12649<\/font><\/td>

\n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t

Success<\/font><\/td> <\/TR>\n

\n\t

10:34:34PM<\/font><\/td>

\n\t

US500<\/font><\/td>

\n\t

3135.02<\/font><\/td>

\n\t

3132<\/font><\/td>

\n\t

3123<\/font><\/td>

\n\t

3032<\/font><\/td>

\n\t

3157<\/font><\/td>

\n\t

3167<\/font><\/td>

\n\t

3186<\/font><\/td>

\n\t

3196<\/font><\/td>

\n\t

3122<\/font><\/td>

\n\t

Success<\/font><\/td> <\/TR>\n

\n\t

10:38:13PM<\/font><\/td>

\n\t

DOW<\/font><\/td>

\n\t

27170<\/font><\/td>

\n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t

Success<\/font><\/td> <\/TR>\n

\n\t

10:42:30PM<\/font><\/td>

\n\t

NASDAQ<\/font><\/td>

\n\t

8858<\/font><\/td>

\n\t

8802<\/font><\/td>

\n\t

8740<\/font><\/td>

\n\t

8374<\/font><\/td>

\n\t

8930<\/font><\/td>

\n\t

8929<\/font><\/td>

\n\t

9004.5<\/font><\/td>

\n\t

9072<\/font><\/td>

\n\t

8836<\/font><\/td>

\n\t

Success<\/font><\/td> <\/TR>\n

\n\t

10:49:11PM<\/font><\/td>

\n\t

JAPAN<\/font><\/td>

\n\t

22138<\/font><\/td>

\n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t <\/td> \n\t

Shambles<\/font><\/td> <\/TR>\n\n<\/TABLE>\n\n

 <\/p>\n

 <\/p>\n

25\/02\/2020 FTSE Closed at 7017 points. Change of -1.94%. Total value traded through LSE was: \u00a3 7,932,387,742 a change of 6.36%<\/h><\/p>\n
24\/02\/2020 FTSE Closed at 7156 points. Change of -3.34%. Total value traded through LSE was: \u00a3 7,457,826,437 a change of 17.05%<\/h><\/p>\n
21\/02\/2020 FTSE Closed at 7403 points. Change of -0.44%. Total value traded through LSE was: \u00a3 6,371,450,688 a change of 1.87%<\/h><\/p>\n
20\/02\/2020 FTSE Closed at 7436 points. Change of -0.28%. Total value traded through LSE was: \u00a3 6,254,655,479 a change of 11.64%<\/h><\/p>\n
19\/02\/2020 FTSE Closed at 7457 points. Change of 1.29%. Total value traded through LSE was: \u00a3 5,602,530,865 a change of -6.87%<\/h><\/p>\n
18\/02\/2020 FTSE Closed at 7362 points. Change of -0.96%. Total value traded through LSE was: \u00a3 6,015,855,072 a change of 44.99%<\/h><\/p>\n
17\/02\/2020 FTSE Closed at 7433 points. Change of 0.32%. Total value traded through LSE was: \u00a3 4,149,027,770 a change of -24.37%<\/h><\/p>\n\n\n","protected":false},"excerpt":{"rendered":"

#Nasdaq #SP500 With a few UK stocks going ballistic due to China Virus activity, a glance at the US highlights a couple of shares enjoying time in the medical spotlight. #Moderna & #Cocrystal both deserve some examination, along with a reminder prices which go up fast can equally reverse with greater brutality. In plain English, … <\/p>\n

Continue reading “Moderna & Cocrystal Pharma 26\/02\/2020”<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1613","post","type-post","status-publish","format-standard","hentry","category-trendsandtargets"],"_links":{"self":[{"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/posts\/1613","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/comments?post=1613"}],"version-history":[{"count":1,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/posts\/1613\/revisions"}],"predecessor-version":[{"id":1614,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/posts\/1613\/revisions\/1614"}],"wp:attachment":[{"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/media?parent=1613"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/categories?post=1613"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/tags?post=1613"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}